Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VTS-270 (Adrabetadex) for Liver and Neurological Disease in NPC1
NCT03887533Phase 2Terminated
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Jan 2020
- Primary completion
- Oct 2021
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Trappsol Cyclo in Niemann-Pick disease type C1 (NPC1), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started Jan 2020; status: terminated.
02
Drugs
Trappsol Cyclo
03
Conditions
Niemann-Pick disease type C1 (NPC1)
Beyond the preview
Go deeper on NCT03887533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03887533.